← Back to Search

Technology-Based Messaging for Increasing COVID-19 Vaccine Uptake

N/A
Recruiting
Research Sponsored by New York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants must be age 18 years or older, able to provide informed consent, able to read and understand English or Spanish
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 weeks
Awards & highlights

Study Summary

This trialwill increase COVID-19 vaccine uptake among PWID by exploring their hesitancy and identifying ways to reduce barriers to vaccination.

Who is the study for?
This trial is for adults over 18 who use injection drugs and haven't been vaccinated against COVID-19. They must understand English or Spanish, be able to consent, and not have been vaccinated before. Pregnant women, those unable to consent, minors, and prisoners are excluded.Check my eligibility
What is being tested?
The study tests whether technology-based messaging with a video can increase COVID-19 vaccine uptake among people who inject drugs compared to messaging without a video.See study design
What are the potential side effects?
Since the interventions involve informational messages with or without videos rather than medical treatments or vaccines themselves, there are no direct side effects associated with this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 or older, can consent to treatment, and understand English or Spanish.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Vaccination series completion
Vaccination uptake at baseline
Vaccination uptake at follow-up
Secondary outcome measures
SARS-CoV-2 literacy at baseline
SARS-CoV-2 literacy at follow-up
Secondary

Trial Design

2Treatment groups
Experimental Treatment
Group I: Video text conditionExperimental Treatment1 Intervention
Participants in the video text condition will receive the text messages designed to increase vaccination among our sample, along with links to iteratively developed intervention videos
Group II: No video conditionExperimental Treatment1 Intervention
Participants in the no video condition will receive weekly text messages designed to increase vaccination among our sample.

Find a Location

Who is running the clinical trial?

New York UniversityLead Sponsor
226 Previous Clinical Trials
313,617 Total Patients Enrolled
New York Harm Reduction EducatorsUNKNOWN
National Institute on Drug Abuse (NIDA)NIH
2,470 Previous Clinical Trials
2,619,231 Total Patients Enrolled

Media Library

No video condition Clinical Trial Eligibility Overview. Trial Name: NCT04924803 — N/A
Coronavirus Research Study Groups: No video condition, Video text condition
Coronavirus Clinical Trial 2023: No video condition Highlights & Side Effects. Trial Name: NCT04924803 — N/A
No video condition 2023 Treatment Timeline for Medical Study. Trial Name: NCT04924803 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are currently involved in this clinical trial?

"Affirmative, the information hosted on clinicaltrials.gov reveals that this trial is currently looking for volunteers. The study was initially published in June of 2022 and was recently modified on October 11th of 2022; it needs to enroll 500 patients from a single medical centre."

Answered by AI

Are there any remaining slots for participants in this experiment?

"Indeed, the clinicaltrials.gov portal confirms that this medical trial is currently accepting new patients. It was initially posted on June 21st 2022 and has since been edited for accuracy as of October 11th 2022; it seeks to recruit 500 participants from one site."

Answered by AI

Who else is applying?

What site did they apply to?
OnPoint NYC
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0
Recent research and studies
clinicaltrials.govStudy
Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs
2022. "Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04924803.
All > Coronavirus
~93 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top